The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Table of Contents
Global Cancer Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Cancer Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Chemotherapy Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Targeted Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Immunotherapy Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Hormonal Therapy (Biologic Therapy) Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.5 Others Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Cancer Drugs Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Cancer Drugs Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Cancer Drugs Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Cancer Drugs Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Cancer Drugs Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Cancer Drugs Market Assessment by Type
8.1 Asia Pacific Cancer Drugs Market Assessment by Application (Consumption and Market Share)
8.2 North America Cancer Drugs Market Assessment by Application (Consumption and Market Share)
8.3 Europe Cancer Drugs Market Assessment by Application (Consumption and Market Share)
8.4 South America Cancer Drugs Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Cancer Drugs Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Roche
9.1.1 Roche Profiles
9.1.2 Roche Product Portfolio
9.1.3 Roche Cancer Drugs Business Performance
9.1.4 Roche Cancer Drugs Business Development and Market Status
9.2 Novartis
9.2.1 Novartis Profiles
9.2.2 Novartis Product Portfolio
9.2.3 Novartis Cancer Drugs Business Performance
9.2.4 Novartis Cancer Drugs Business Development and Market Status
9.3 Celgene
9.3.1 Celgene Profiles
9.3.2 Celgene Product Portfolio
9.3.3 Celgene Cancer Drugs Business Performance
9.3.4 Celgene Cancer Drugs Business Development and Market Status
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Profiles
9.4.2 Bristol-Myers Squibb Product Portfolio
9.4.3 Bristol-Myers Squibb Cancer Drugs Business Performance
9.4.4 Bristol-Myers Squibb Cancer Drugs Business Development and Market Status
9.5 Amgen
9.5.1 Amgen Profiles
9.5.2 Amgen Product Portfolio
9.5.3 Amgen Cancer Drugs Business Performance
9.5.4 Amgen Cancer Drugs Business Development and Market Status
9.6 Johnson & Johnson
9.6.1 Johnson & Johnson Profiles
9.6.2 Johnson & Johnson Product Portfolio
9.6.3 Johnson & Johnson Cancer Drugs Business Performance
9.6.4 Johnson & Johnson Cancer Drugs Business Development and Market Status
9.7 Pfizer
9.7.1 Pfizer Profiles
9.7.2 Pfizer Product Portfolio
9.7.3 Pfizer Cancer Drugs Business Performance
9.7.4 Pfizer Cancer Drugs Business Development and Market Status
9.8 Takeda
9.8.1 Takeda Profiles
9.8.2 Takeda Product Portfolio
9.8.3 Takeda Cancer Drugs Business Performance
9.8.4 Takeda Cancer Drugs Business Development and Market Status
9.9 Eli Lilly
9.9.1 Eli Lilly Profiles
9.9.2 Eli Lilly Product Portfolio
9.9.3 Eli Lilly Cancer Drugs Business Performance
9.9.4 Eli Lilly Cancer Drugs Business Development and Market Status
9.10 AstraZeneca
9.10.1 AstraZeneca Profiles
9.10.2 AstraZeneca Product Portfolio
9.10.3 AstraZeneca Cancer Drugs Business Performance
9.10.4 AstraZeneca Cancer Drugs Business Development and Market Status
9.11 Astellas
9.12 Merck & Co.
9.13 Sanofi
9.14 Bayer
9.15 Biogen Idec
9.16 Eisai
9.17 Teva
9.18 Otsuka
9.19 Merck KGaA
9.20 Ipsen
9.21 AbbVie
9.22 Gilead Sciences
10 World Cancer Drugs Market Assessment by Players
10.1 Global Cancer Drugs Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Cancer Drugs Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Cancer Drugs Price (USD/Unit) of Players 2014-2020
10.4 Global Cancer Drugs Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Cancer Drugs Sales Assessment of Players 2014-2020
11.1.2 North America Cancer Drugs Revenue Assessment of Players 2014-2020
11.1.3 North America Cancer Drugs Price Assessment of Players 2014-2020
11.1.4 North America Cancer Drugs Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Cancer Drugs Sales Assessment of Players 2014-2020
11.2.2 Europe Cancer Drugs Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Cancer Drugs Price Assessment of Players 2014-2020
11.2.4 Europe Cancer Drugs Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Cancer Drugs Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Cancer Drugs Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Cancer Drugs Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Cancer Drugs Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Cancer Drugs Sales Assessment of Players 2014-2020
11.4.2 South America Cancer Drugs Revenue Assessment of Players 2014-2020
11.4.3 South America Cancer Drugs Price Assessment of Players 2014-2020
11.4.4 South America Cancer Drugs Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Cancer Drugs Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Cancer Drugs Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Cancer Drugs Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Cancer Drugs Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Cancer Drugs Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Cancer Drugs Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Cancer Drugs Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Cancer Drugs Sales by Countries/Regions 2014-2020
12.2.2 North America Cancer Drugs Revenue by Countries/Regions 2014-2020
12.2.3 North America Cancer Drugs Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Cancer Drugs Sales by Countries/Regions 2014-2020
12.3.2 Europe Cancer Drugs Revenue by Countries/Regions 2014-2020
12.3.3 Europe Cancer Drugs Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Cancer Drugs Sales by Countries/Regions 2014-2020
12.4.2 South America Cancer Drugs Revenue by Countries/Regions 2014-2020
12.4.3 South America Cancer Drugs Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Cancer Drugs Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Cancer Drugs Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Cancer Drugs Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Cancer Drugs Sales & Revenue Forecast 2021-2026
14.1 World Cancer Drugs Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Cancer DrugsSales and Market Share by Regions
14.1.2 World Cancer DrugsRevenue and Market Share by Regions
15 Asia Cancer Drugs Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Chemotherapy
15.1.2 Targeted Therapy
15.1.3 Immunotherapy
15.1.4 Hormonal Therapy (Biologic Therapy)
15.1.5 Others
15.2 Consumption Forecast by Application, 2021-2026
16 North America Cancer Drugs Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Chemotherapy
16.1.2 Targeted Therapy
16.1.3 Immunotherapy
16.1.4 Hormonal Therapy (Biologic Therapy)
16.1.5 Others
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Cancer Drugs Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Chemotherapy
17.1.2 Targeted Therapy
17.1.3 Immunotherapy
17.1.4 Hormonal Therapy (Biologic Therapy)
17.1.5 Others
17.2 Consumption Forecast by Application, 2021-2026
18 South America Cancer Drugs Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Chemotherapy
18.1.2 Targeted Therapy
18.1.3 Immunotherapy
18.1.4 Hormonal Therapy (Biologic Therapy)
18.1.5 Others
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Cancer Drugs Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Chemotherapy
19.1.2 Targeted Therapy
19.1.3 Immunotherapy
19.1.4 Hormonal Therapy (Biologic Therapy)
19.1.5 Others
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Cancer Drugs Price (USD/Unit) Trend 2021-2026
20.2 Global Cancer Drugs Gross Profit Trend 2021-2026
21 Conclusion
Price : US$ 3,500 | Date : Apr 2024 |
Category : Manufacturing and Construction | Pages : 139 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Services | Pages : 120 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Manufacturing and Construction | Pages : 125 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Services | Pages : 150 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 221 |
We will be happy to help you find what you need. Please call us or write to us: